Christopher Harvey

Christopher Harvey has held a number of positions in the scientific field, beginning in 2011 as a Postdoctoral Fellow at both Harvard Medical School and the Dana-Farber Cancer Institute. In 2014, they were appointed Director & Head of Preclinical Sciences at Jounce Therapeutics, Inc. and, in 2021, they became the Head of Research at Phenomic AI.

Christopher Harvey received their Bachelor of Science in Biochemistry from Georgetown University and their Doctor of Philosophy from The Johns Hopkins University.